JXSB2400135 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-10-23 | | | | | view |
JXSB2400136 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-10-23 | | | | | view |
JTS2400098 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products | Disposable Import Drug Application | 2024-09-21 | | | | | view |
JXSB2400061 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-05-28 | | | | | view |
JXSL2400078 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2024-04-20 | | | | | view |
JXSB2400013 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-02-05 | | | | | view |
JXSL2300160 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-09-01 | | | | | view |
JXSL2300135 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-07-22 | | | | | view |
JXSL2300115 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-06-27 | | | | | view |
JXSL2300092 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2023-05-12 | | | | | view |
JXSL2101106 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-09-02 | | | | | view |
JXSL2000211 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products(1) | Import Drug Application | 2020-12-14 | AstraZeneca AB | AstraZeneca AB | In Review | 2020-12-03 | view |
JXSL1600060 | Anifrolumab注射液 | anifrolumab | Injection | Biological Products | Import Drug Application | 2016-11-10 | | Medimmune LLC | Certificate Issued | 2017-11-01 | view |